Publication Date
| In 2026 | 0 |
| Since 2025 | 0 |
| Since 2022 (last 5 years) | 0 |
| Since 2017 (last 10 years) | 1 |
| Since 2007 (last 20 years) | 1 |
Descriptor
| At Risk Persons | 1 |
| Congenital Impairments | 1 |
| Contraception | 1 |
| Depression (Psychology) | 1 |
| Drug Use | 1 |
| Epilepsy | 1 |
| Females | 1 |
| Health Personnel | 1 |
| Informed Consent | 1 |
| Intellectual Disability | 1 |
| Mental Disorders | 1 |
| More ▼ | |
Source
| British Journal of Learning… | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkSawhney, Indermeet; Zia, Asif; Adams, Danielle; Gates, Bob – British Journal of Learning Disabilities, 2019
Background: It is well established that valproate, and its valproic acid, sodium valproate, and valproate semisodium forms is a highly teratogenic drug and evidence suggests that use in pregnancy leads to physical birth defects in 10% of children born compared with a background rate of 2% to 3%. Congenital malformations associated with valproate…
Descriptors: Females, Intellectual Disability, At Risk Persons, Pregnancy
